Braun Stacey Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-9,750
| Closed | -$863K | – | 116 |
|
|
2023
Q3 | $863K | Sell |
9,750
-177,727
| -95% | -$15.7M | 0.04% | 104 |
|
|
2023
Q2 | $16.3M | Sell |
187,477
-193,853
| -51% | -$16.8M | 0.76% | 61 |
|
|
2023
Q1 | $37.1M | Buy |
381,330
+171,529
| +82% | +$16.7M | 0.97% | 41 |
|
|
2022
Q4 | $21.7M | Buy |
209,801
+38,883
| +23% | +$4.02M | 1.24% | 21 |
|
|
2022
Q3 | $14.5M | Buy |
+170,918
| New | +$14.5M | 0.88% | 53 |
|